A detailed history of Kovack Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 15,851 shares of ABBV stock, worth $3.13 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
15,851
Previous 16,826 5.79%
Holding current value
$3.13 Million
Previous $3.06 Million 11.29%
% of portfolio
0.31%
Previous 0.37%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $150,920 - $176,241
-975 Reduced 5.79%
15,851 $2.72 Million
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $371,901 - $423,746
2,327 Added 16.05%
16,826 $3.06 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $19,126 - $21,540
-139 Reduced 0.95%
14,499 $2.25 Million
Q3 2023

Oct 19, 2023

SELL
$133.59 - $154.65 $27,252 - $31,548
-204 Reduced 1.37%
14,638 $2.18 Million
Q2 2023

Jul 21, 2023

SELL
$132.51 - $164.9 $50,618 - $62,991
-382 Reduced 2.51%
14,842 $2 Million
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $41,647 - $47,963
288 Added 1.93%
15,224 $2.43 Million
Q4 2022

Feb 22, 2023

SELL
$138.31 - $165.87 $86,996 - $104,332
-629 Reduced 4.04%
14,936 $2.42 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $730,505 - $837,840
-5,443 Reduced 25.91%
15,565 $2.09 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $1.28 Million - $1.63 Million
-9,327 Reduced 30.75%
21,008 $3.22 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $226,213 - $280,667
1,714 Added 5.99%
30,335 $4.92 Million
Q4 2021

Jan 18, 2022

SELL
$107.43 - $135.93 $156,525 - $198,050
-1,457 Reduced 4.84%
28,621 $3.88 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $556,365 - $631,558
5,229 Added 21.04%
30,078 $3.24 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $34,508 - $38,444
328 Added 1.34%
24,849 $2.8 Million
Q1 2021

May 04, 2021

SELL
$102.3 - $112.62 $64,551 - $71,063
-631 Reduced 2.51%
24,521 $2.65 Million
Q4 2020

Jan 14, 2021

BUY
$80.49 - $108.67 $55,860 - $75,416
694 Added 2.84%
25,152 $2.7 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $614,428 - $721,136
7,152 Added 41.33%
24,458 $2.14 Million
Q2 2020

Jul 31, 2020

SELL
$73.37 - $98.18 $74,984 - $100,339
-1,022 Reduced 5.58%
17,306 $1.7 Million
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $391,773 - $593,976
-6,074 Reduced 24.89%
18,328 $1.4 Million
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $170,154 - $212,899
2,359 Added 10.7%
24,402 $2.16 Million
Q3 2019

Oct 31, 2019

BUY
$62.98 - $75.72 $532,873 - $640,666
8,461 Added 62.3%
22,043 $1.67 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $40,077 - $51,227
-610 Reduced 4.3%
13,582 $988,000
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $37,027 - $43,579
-480 Reduced 3.27%
14,192 $1.14 Million
Q4 2018

Feb 06, 2019

SELL
$77.85 - $96.01 $344,019 - $424,268
-4,419 Reduced 23.15%
14,672 $1.35 Million
Q3 2018

Oct 09, 2018

BUY
$88.91 - $98.84 $250,548 - $278,531
2,818 Added 17.32%
19,091 $1.81 Million
Q2 2018

Aug 01, 2018

BUY
$89.78 - $106.23 $9,606 - $11,366
107 Added 0.66%
16,273 $1.51 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $210,334 - $281,658
-2,286 Reduced 12.39%
16,166 $2.31 Million
Q4 2017

May 15, 2018

BUY
$89.56 - $98.21 $96,277 - $105,575
1,075 Added 6.19%
18,452 $1.67 Million
Q4 2017

Feb 01, 2018

BUY
$89.56 - $98.21 $730,540 - $801,098
8,157 Added 88.47%
17,377 $1.68 Million
Q3 2017

Aug 02, 2018

SELL
$69.85 - $89.22 $251,040 - $320,656
-3,594 Reduced 28.05%
9,220 $819,000
Q2 2017

Aug 30, 2018

BUY
N/A
4,245 Added 49.54%
12,814 $929,000
Q1 2017

Sep 05, 2018

SELL
N/A
-293 Reduced 3.31%
8,569 $558,000
Q4 2016

Sep 10, 2018

BUY
N/A
1,167 Added 15.17%
8,862 $555,000
Q3 2016

Sep 25, 2018

SELL
N/A
-692 Reduced 8.25%
7,695 $485,000
Q2 2016

Oct 01, 2018

BUY
N/A
4,881 Added 139.22%
8,387 $519,000
Q1 2016

Oct 12, 2018

BUY
N/A
3,506 New
3,506 $200,000
Q4 2015

Oct 18, 2018

SELL
N/A
-8,032 Closed
0 $0
Q3 2015

Oct 29, 2018

BUY
N/A
8,032
8,032 $437,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.